Beiersdorf Aktiengesellschaft (OTCMKTS:BDRFF) Receives Average Recommendation of “Reduce” from Analysts

Beiersdorf Aktiengesellschaft (OTCMKTS:BDRFF) has received a consensus recommendation of “Reduce” from the six ratings firms that are presently covering the company, Marketbeat reports. Two research analysts have rated the stock with a sell recommendation and four have given a hold recommendation to the company.

Several brokerages have issued reports on BDRFF. JPMorgan Chase & Co. reaffirmed a “neutral” rating on shares of Beiersdorf Aktiengesellschaft in a research note on Wednesday, March 18th. Berenberg Bank reaffirmed a “hold” rating on shares of Beiersdorf Aktiengesellschaft in a research note on Monday, March 23rd. UBS Group raised Beiersdorf Aktiengesellschaft from a “sell” rating to a “neutral” rating in a research note on Tuesday, March 31st. Morgan Stanley downgraded shares of Beiersdorf Aktiengesellschaft from an “equal weight” rating to an “underweight” rating in a research note on Monday, March 16th. Finally, Royal Bank Of Canada downgraded shares of Beiersdorf Aktiengesellschaft from a “sector perform” rating to an “underperform” rating in a research note on Tuesday, March 10th.

Beiersdorf Aktiengesellschaft Price Performance

BDRFF opened at $82.22 on Wednesday. The business’s fifty day simple moving average is $86.66 and its 200 day simple moving average is $101.39. Beiersdorf Aktiengesellschaft has a 52 week low of $81.25 and a 52 week high of $135.52.

About Beiersdorf Aktiengesellschaft

Beiersdorf Aktiengesellschaft is a global consumer goods company headquartered in Hamburg, Germany, with a history dating back to its founding in 1882 by pharmacist Paul C. Beiersdorf. The company is best known for its skincare brands, including NIVEA, Eucerin, La Prairie and Labello, as well as its tesa division, which produces self-adhesive products and industrial tapes. Over its long history, Beiersdorf has built a reputation for innovation in dermatological research and product development, introducing pioneering formulations that span mass-market and premium segments.

The company’s operations are organized into two main business divisions.